Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment

Journal of Cellular Physiology

Volumn 221, Issue 3, 2009, Pages 603-608

  Mrabat, Hicham ^a   Garg, Hari G ^a   Hales, Charles A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; HEPARIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; COLLAGEN TYPE 11; CYCLINE; DRUG DERIVATIVE; PARP PROTEIN, BOS TAURUS;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTERY MUSCLE; ARTICLE; CELL DEATH; CELL GROWTH; CELL SUBPOPULATION; CONTROLLED STUDY; COW; EXPOSURE; FLOW CYTOMETRY; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY ARTERY SMOOTH MUSCLE CELL; SMOOTH MUSCLE FIBER; ANIMAL; CATTLE; CELL CULTURE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; METABOLISM; NECROSIS; PATHOLOGY;

BOVINAE; RATTUS;

ANIMALS; APOPTOSIS; CASPASE 3; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE XI; HEPARIN; MYOCYTES, SMOOTH MUSCLE; NECROSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PULMONARY ARTERY;

EID: 70449732292     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21891     Document Type: Article

References (36)

1. Bârzu T, Herbert JM, Desmoulière A, Carayon P, Pascal M. 1994. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment. J Cell Physiol 160:239-248.
2. Bennett MR, O'Sullivan M. 2001. Mechanisms of angioplasty and stent restenosis: Implications for design of rational therapy. Pharmacol Ther 91:149-166. (Pubitemid 33139799)
3. Caleb BL, Hardenbrook M, Cherington V, Castellot JJ, Jr. 1996. Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin. J Cell Physiol 167:185-195.
4. Chan P, Patel M, Betteridge L, Munro E, Schachter M, Wolfe J, Sever P. 1993. Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis. Lancet 341:341-342. (Pubitemid 23039702)
5. Cindhuchao N, Quinn DA, Garg HG, Hales CA. 2003. Heparin inhibits SMC growth in the presence of human and fetal bovine serum. Biochem Biophys Res Commun 302:84-88. (Pubitemid 36268922)
6. Clowes AW, Clowes MM. 1985. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab Invest 52:611-616.
7. Clowes AW, Karnovsky MJ. 1977. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. Lab Invest 36:452-464.
8. Friesen C, Lubatschofski A, Glatting G, Debatin KM, Reske SN. 2008. Activation of intrinsic apoptotic pathway by Re-188 irradiation and paclitaxel in coronary artery smooth muscle cells. Q J Nucl Med Mol Imaging 52:289-295.
9. Garg HG, Thompson BT, Hales CA. 2000. Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 279:778-779.
10. Garg HG, Hales CA, Yu L, Butler M, Islam T, Xie J, Linhardt RJ. 2006. Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl Low molecular-weight heparin derivative. Carbohydr Res 341:2607-2612. (Pubitemid 44427785)
11. Halayko AJ, Stephens NL. 1994. Potential role for phenotypic modulation of bronchial smooth muscle cells in chronic asthma. Can J Physiol Pharmacol 72:1448-1457.
12. Hales CA, Kradin RL, Brandstetter RD, Zhu YJ. 1983. Impairment of hypoxic pulmonary artery remodeling by heparin in mice. Am Rev Respir Dis 128:747-751.
13. Hills FA, Abrahams VM, González-Timón B, Francis J, Cloke B, Hinkson L, Rai R, Mor G, Regan L, Sullivan M, Lam EW, Brosens JJ. 2006. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 12:237-243. (Pubitemid 43779075)
14. Hoover RL, Rosenberg R, Haering W, Karnovsky MJ. 1980. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res 47:578-583. (Pubitemid 10009675)
15. Horiuchi A, Nikaido T, Ya-Li Z, Ito K, Orii A, Fujii S. 1996. Heparin inhibits proliferation of myometrial and leiomyomal smooth muscle cells through the induction of alpha-smooth muscle actin, calponin h1 and p27. Mol Hum Reprod 5:139-145. (Pubitemid 29067713)
16. Jeffery TK, Wanstall JC. 2001. Pulmonary vascular remodeling: A target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 92:1-20. (Pubitemid 34032020)
17. Kelman Z. 1997. PCNA: Structure, functions and interactions. Oncogene 14:629-640.
18. Khoury J, Langleben D. 2000. Heparin-like molecules inhibit pulmonary vascular pericyte proliferation in vitro. Am J Physiol Lung Cell Mol Physiol 279:L252-L261. (Pubitemid 30676958)
19. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. 1994. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347. (Pubitemid 24300618)
20. Lusis AJ. 2000. Atherosclerosis. Nature 407:233-241.
21. Mason HR, Nowak RA, Morton CC, Castellot JJ, Jr. 2003. Heparin inhibits the motility and proliferation of human myometrial and leiomyoma smooth muscle cells. Am J Pathol 162:1895-1904.
22. Mathews MB, Bernstein RM, Franza BR, Jr., Garrels JI. 1984. Identity of the proliferating cell nuclear antigen and cyclin. Nature 309:374-376. (Pubitemid 14145846)
23. Matsumoto Y, Shimokawa H, Morishige K, Eto Y, Takeshita A. 2002. Reduction in neointimal formation with a stent coated with multiple layers of releasable heparin in porcine coronary arteries. J Cardiovasc Pharmacol 39:513-522. (Pubitemid 34252386)
24. Ottlinger ME, Pukac LA, Karnovsky MJ. 1993. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J Biol Chem 268:19173-19176. (Pubitemid 23270681)
25. Pelisek J, Armeanu S, Nikol S. 2001. Quiescence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors. Cell Prolif 34:305-320. (Pubitemid 32939477)
26. Pukac LA, Hirsch GM, Lormeau JC, Petitou M, Choay J, Karnovsky MJ. 1991. Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo. Am J Pathol 139:1501-1509.
27. Rabinovitch M. 2004. The mouse through the looking glass: A new door into the pathophysiology of pulmonary hypertension. Circ Res 94:1001-1004. (Pubitemid 38579692)
28. Ross R. 1971. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50:172-186.
29. San Antonio JD, Karnovsky MJ, Ottlinger ME, Schillig R, Pukac LA. 1993. Isolation of heparin-insensitive aortic smooth muscle cells. Growth and differentiation. Arterioscler Thromb 13:748-757.
30. Schwartz SM, Foy L, Bowen-Pope DF, Ross R. 1990. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol 136:1417-1428. (Pubitemid 20210340)
31. Sindermann JR, March KL, 1998. Heparin responsiveness in vitro as a prognostic tool for vascular graft stenosis. A tale of two cell types? Circulation 97:2486-2490.
32. Thompson BT, Spence CR, Janssens SP, Joseph PM, Hales CA. 1994. Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency. Am J Respir Crit Care Med 149:1512-1517.
33. Yu L, Quinn DA, Garg HG, Hales CA. 2005. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 97:937-945. (Pubitemid 41552680)
34. Yu L, Quinn DA, Garg HG, Hales CA. 2006. Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun 345:1565-1572. (Pubitemid 43817908)
35. Yu L, Quinn DA, Garg HG, Hales CA. 2008. Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling. Am J Respir Crit Care Med 177:1276-1284. (Pubitemid 351860938)
36. Zargham R. 2008. Preventing restenosis after angioplasty: A multistage approach. Clin Sci (Lond) 114:257-264. (Pubitemid 351294001)